Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Velocity Clinical Research Strengthens Management Team amid European Expansion
The world’s largest integrated clinical trial site organisation, Velocity Clinical Research (“Velocity”), today announces it […]
Carrum Health Taps Pallav Sharda as Chief Platform Officer to Scale Technology Platform
Carrum Health, the first digital health company connecting employers and employees to Centers of Excellence […]
Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer
Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the […]
World-renowned Urologist Professor Prokar Dasgupta Joins MysteryVibe as Chief Medical Officer
MysteryVibe announces the strategic hire of Professor Prokar Dasgupta as their new Chief Medical Officer (CMO), to support the development […]
SynOx Therapeutics Further Strengthens Team with Appointments of Chief Medical Officer and Chief Technology Officer
SynOx Therapeutics Limited (“SynOx” or the “Company”), the late-stage clinical biopharmaceutical company developing emactuzumab for […]
SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer
CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI-data driven proteomics technology, […]
Amanda Pritchard Appointed NHS Chief Executive
Amanda Pritchard has today been appointed as the new Chief Executive Officer of NHS England. […]
Inceptor Bio Announces the Appointment of Dr. Mark J. Gilbert as Chair of its Scientific Advisory Board
Inceptor Bio, a Research Triangle Park, North Carolina-based cell and gene therapy biotechnology company, announced today […]
Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, […]
X-Vax Technology Appoints Varsha K. Jain, MD as Chief Clinical Development Officer
X-Vax Technology, Inc. (X-VAX®), a biotechnology company developing vaccines based on a new approach that […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more